Therapeutic Potential of Valproic Acid for Postviral Olfactory Dysfunction: A Single-Arm Pilot Study.

Takao OgawaKoji MatsumotoIchiro TojimaHirotaka Kikuoka Daiki Hira Takeshi Shimizu

Published in: The Annals of otology, rhinology, and laryngology (2022)

VPA seems to be a safe treatment option in patients with PVOD. The effects of VPA treatment for PVOD patients should be studied with a controlled study design in the future.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
oxidative stress
combination therapy